CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 2, 2022 · earnings

EBS earnings: a negative outcome, -11.6%

On August 2, 2022, Emergent BioSolutions Inc. reached its earnings. The result was a negative outcome, and the stock moved -11.6% in the window around the event. It had already run +8.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$34.23
1d before
$30.26
Event day
$30.72
1d after
$31.65
5d after

Pre-catalyst setup

+8.8%
30-day run-up
5310%
30-day volatility
1.1×
volume spike